|
|
Article: Novel Lipopolysaccharide Vaccine Immunogenic in Rabbit Model.
- Article from:
- Vaccine Weekly
- Article date:
- November 15, 2000
CopyrightCOPYRIGHT 2000 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2000 NOV 15 - (NewsRx.com) --
Preclinical data of a novel liposomal complete-core lipopolysaccharide (LPS) vaccine against numerous bacterial pathogens are encouraging.
"Low preoperative anti-endotoxin antibody levels have been shown to be an independent predictor of adverse outcome following cardiac surgery," stated Elliott Bennett-Guerrero and colleagues from Columbia University College, New York. "Our objective is to develop a prophylactic vaccine strategy that can be evaluated in surgical patients and other high-risk hospitalized patients."
Bennett-Guerrero et al. presented data from their study at the annual meeting of the American ...